Penumbra, Inc. (PEN)
NYSE: PEN · Real-Time Price · USD
233.39
+1.51 (0.65%)
Jul 23, 2025, 4:00 PM - Market closed

Company Description

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally.

The company offers peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX.

It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX, BENCHMARK, BMX, DDC, MIDWAY, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization device, aspiration tubing, and aspiration pump under the Penumbra RED, SENDit, JET, ACE, BMX, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as detachable coils to treat patients with a wide range of neurovascular lesions under the Penumbra SMART COIL and Penumbra SwiftPAC Coil brands; and POD400 and PAC400 brands.

In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products.

Further, it offers neurosurgical tools comprising Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum.

The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.

Penumbra, Inc.
Penumbra logo
CountryUnited States
Founded2004
IPO DateSep 18, 2015
IndustryMedical Devices
SectorHealthcare
Employees4,500
CEOAdam Elsesser

Contact Details

Address:
One Penumbra Place
Alameda, California 94502
United States
Phone510 748 3200
Websitepenumbrainc.com

Stock Details

Ticker SymbolPEN
ExchangeNYSE
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
CIK Code0001321732
CUSIP Number70975L107
ISIN NumberUS70975L1070
SIC Code3841

Key Executives

NamePosition
Adam Elsesser J.D.Co-Founder, Chairman, President and Chief Executive Officer
Dr. Arani Bose M.D.Co-Founder and Director
Maggie S. YuenChief Financial Officer
Lambert ShiuChief Accounting Officer
Johanna Roberts J.D.Executive Vice President, General Counsel and Secretary
Ben SorciExecutive Vice President of Operations
Pankaj TiwariExecutive Vice President and Chief Information Officer
Jee Hamlyn-HarrisInvestor Relations Officer
Ben TompkinsExecutive Vice President of Development and Compliance
Shruthi NarayanPresident of Interventional

Latest SEC Filings

DateTypeTitle
Jul 23, 2025144Filing
Jul 9, 2025144Filing
Jul 1, 2025144Filing
Jun 25, 2025144Filing
Jun 16, 2025144Filing
Jun 11, 2025144Filing
May 30, 2025SDForm - SD
May 30, 20258-KCurrent Report
May 28, 2025144Filing
May 15, 2025144Filing